Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/wiley/in-vivo-dopamine-agonist-and-antagonist-activities-of-a-series-of-ieqUwkeOjH
References (6)
-
P. Voigtlander, J. Althaus, M. Ochoa, G. Neff (1989)
Dopamine receptor agonist activity of U‐66444B and its enantiomers: Evaluation of functional, biochemical, and pharmacokinetic propertiesDrug Development Research, 17
-
J. Neumeyer, M. Froimowitz, R. Baldessarini, A. Campbell, Y. Gao (1988)
Neuropharmacology and stereochemistry of dopamine receptor agonist and antagonist enantiomeric pairs.Journal of receptor research, 8 1-4
-
L. Arvidsson, U. Hacksell, J. Nilsson, S. Hjorth, A. Carlsson, P. Lindberg, D. Sanchez, H. Wikstroem (1981)
8-Hydroxy-2-(di-n-propylamino)tetralin, a new centrally acting 5-hydroxytryptamine receptor agonist.Journal of medicinal chemistry, 24 8
-
G. Olson, H. Cheung, K. Morgan, J. Blount, L. Todaro, L. Berger, A. Davidson, E. Boff (1981)
A dopamine receptor model and its application in the design of a new class of rigid pyrrolo[2,3-g]isoquinoline antipsychotics.Journal of medicinal chemistry, 24 9
-
P. Seeman, M. Watanabe, D. Grigoriadis, J. Tedesco, S. George, U. Svensson, J. Nilsson, J. Neumeyer (1985)
Dopamine D2 receptor binding sites for agonists. A tetrahedral model.Molecular pharmacology, 28 5
-
C. Euvrard, L. Ferland, M. Fortin, C. Oberlander, F. Labrie, J. Boissier (1981)
Dopaminergic activity of some simplified ergoline derivativesDrug Development Research, 1
- Publisher
- Wiley
- Copyright
- Copyright © 1990 Wiley‐Liss, Inc.
- ISSN
- 0272-4391
- eISSN
- 1098-2299
- DOI
- 10.1002/ddr.430210107
- Publisher site
- See Article on Publisher Site
Abstract
A series of structurally rigid compounds (2‐amino‐2, 3‐dihydro‐3H‐phenalenes) has been synthesized for dopamine (DA) agonist activities. One member (U‐66444B) in the series has been reported as a potent and selective agonist for presynaptic DA receptors. Among close analogues of U‐66444B, we have identified two compounds with DA antagonist activities by behavioral and biochemical endpoints. The distinguishing chemical features of these two antagonists are methyl substitutions on the amino nitrogen and a phenolic hydroxy group having a most proximal position to the amino group. The structure‐activity relationship in this series of compounds may contribute to future design of DA agonists and antagonists.
Journal
Drug Development Research – Wiley
Published: Jan 1, 1990
Keywords: neuroleptic; dopamine agonists; dopamine antamine antagonists; amino dihydrophenalenes